Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
McKesson
Express Scripts
Medtronic
Johnson and Johnson

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

RENESE Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Which patents cover Renese, and when can generic versions of Renese launch?

Renese is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in RENESE is polythiazide; reserpine. There is one drug master file entry for this compound. Additional details are available on the polythiazide; reserpine profile page.

Summary for RENESE
Drug patent expirations by year for RENESE
Synonyms for RENESE
2-Methyl-3-(beta,beta,beta-trifluoroethylthiomethyl)-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-dioxide (8CI, 9CI)
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide (8CI, 9CI)
2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide
346-18-9
6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1
6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1?^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydrobenzo[e][1,2,4]thiadiazine-7-sulfonamide
6-chloro-2-methyl-1,1-dioxo-3-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide
6-Chloro-2-methyl-3-([(2,2,2-trifluoroethyl)sulfanyl]methyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #
6-CHLORO-2-METHYL-3-[[(2,2,2-TRIFLUOROETHYL)SULFANYL]METHYL]-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE
6-chloro-2-methyl-3-{[(2,2,2-trifluoroethyl)thio]methyl}-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,2,2-trifluoroethyl)thio]methyl]-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-2-methyl-7-sulphamoyl-3-(2,2,2-trifluoroethylthiomethyl)-2H-benzo-1,2,4-thiadiazine 1,1-dioxide
AC1L1J55
AC1Q6TPT
ACM346189
API0006930
BRN 0770371
C07766
C11H13ClF3N3O4S3
CAS-346-18-9
CCRIS 6094
CHEBI:8327
CHEMBL1587
CYLWJCABXYDINA-UHFFFAOYSA-N
D00657
DB01324
Drenusil
DSSTox_CID_5939
DSSTox_GSID_25939
DSSTox_RID_77972
EINECS 206-468-4
FT-0673974
GTPL7274
HSDB 850
KS-1466
LS-1223
NCGC00182076-02
NCGC00182076-03
Nephril
NSC 108161
NSC-108161
NSC108161
P 2525
P-2525
Politiazida
Politiazida [INN-Spanish]
polythiazide
Polythiazide (JAN/USAN/INN)
Polythiazide [USAN:INN:BAN:JAN]
Polythiazide [USAN:USP:INN:BAN:JAN]
Polythiazidum
Polythiazidum [INN-Latin]
Renese (TN)
SCHEMBL27909
SR-01000883970
SR-01000883970-1
Tox21_113137
Tox21_113137_1
WLN: T66 BSWN EM DHJ C1 D1S1XFFF HG ISZW

US Patents and Regulatory Information for RENESE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer RENESE polythiazide TABLET;ORAL 012845-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer RENESE-R polythiazide; reserpine TABLET;ORAL 013636-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer RENESE polythiazide TABLET;ORAL 012845-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer RENESE polythiazide TABLET;ORAL 012845-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Merck
Medtronic
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.